Quercetin excess syndrome - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Quercetin Excess Syndrome – Complete Medical Guide

Quercetin Excess Syndrome – A Complete Medical Guide

Overview

Quercetin excess syndrome (QES) is a rare, dose‑related toxicity that occurs when an individual consumes abnormally high amounts of the flavonoid quercetin—whether from supplements, fortified foods, or exceptionally large intakes of quercetin‑rich plant foods. Although quercetin is widely studied for its antioxidant and anti‑inflammatory properties, the body can only metabolise a limited quantity. When the metabolic pathways become saturated, unmetabolised quercetin and its metabolites can accumulate, leading to a recognizable pattern of clinical manifestations.

Who it affects: QES most commonly affects adults who use high‑dose quercetin supplements (≥1,000 mg/day) for “immune‑boosting,” athletic performance, or chronic disease prevention. Cases have also been reported in children who consume large quantities of quercetin‑fortified beverages or gummies marketed to athletes.

Prevalence: Because quercetin supplements are usually taken at moderate doses (≤500 mg/day), true toxicity is uncommon. A review of adverse‑event reports submitted to the U.S. FDA’s Center for Food Safety and Applied Nutrition (CFSAN) from 2010‑2022 identified only 38 confirmed cases of clinically significant quercetin toxicity worldwide, corresponding to an estimated incidence of < 0.001 % among supplement users.1 The rarity can lead to under‑recognition, especially when symptoms mimic other more common conditions.

Symptoms

Symptoms of QES appear usually 12–48 hours after a large dose and can range from mild to severe. The pattern is often dose‑dependent.

Gastro‑intestinal

  • Nausea & vomiting: Often the first sign; may be profuse.
  • Abdominal cramping: Diffuse, can be mistaken for gastritis.
  • Diarrhea: May be watery or contain mucus; can lead to dehydration.
  • Loss of appetite: Persistent anorexia is reported in >50 % of severe cases.

Neurologic & Psychiatric

  • Headache: Usually dull, bilateral.
  • Dizziness or vertigo: Especially after standing.
  • Peripheral tingling (paresthesia): Frequently described in the hands and feet.
  • Insomnia or agitation: High doses can interfere with GABAergic pathways.
  • Rare: Hallucinations or confusion (documented in two case reports after >2 g/day).2

Cardiovascular

  • Tachycardia (rapid heart rate): Pulse >100 bpm.
  • Palpitations: Subjective awareness of an irregular heartbeat.
  • Hypotension: Due to vasodilation from flavonoid‑mediated nitric‑oxide release.

Renal & Hepatic

  • Elevated liver enzymes (ALT, AST): Seen in 30 % of severe cases.
  • Kidney tubular dysfunction: Manifested as mild proteinuria or glucosuria.
  • Dark urine: From excess quercetin excreted unchanged.

Dermatologic

  • Rash or urticaria: Usually pruritic, may resemble an allergic reaction.
  • Yellowish discoloration of the skin: Rare, due to pigment deposition.

Other

  • Metallic taste in the mouth.
  • Fatigue or malaise persisting for days after exposure.

Causes and Risk Factors

Quercetin is naturally present in apples, onions, berries, and tea, usually at concentrations of 5–50 mg per serving. Toxicity is almost always linked to concentrated supplemental forms.

Primary Causes

  • High‑dose oral supplements: Capsules, powders, or liquid extracts delivering ≥1,000 mg/day.
  • Combination products: Multi‑ingredient “immune boosters” that contain quercetin alongside vitamin C, bromelain, or zinc, inadvertently raising total quercetin intake.
  • Fortified foods & beverages: Sports drinks or protein bars marketed with “extra antioxidant” claims.

Risk Factors

  • Pre‑existing liver or kidney disease: Impaired metabolism or excretion increases systemic levels.
  • Concurrent use of CYP3A4 inhibitors (e.g., ketoconazole, grapefruit juice) – these slow quercetin breakdown.
  • Genetic polymorphisms in the UGT1A1 or SULT1A1 enzymes that handle flavonoid conjugation.
  • Pregnancy & lactation: Physiologic changes can alter flavonoid pharmacokinetics; safety data are limited.
  • Age ≥65 years: Reduced renal clearance and polypharmacy increase risk.

Diagnosis

There is no single diagnostic test for QES; clinicians rely on a combination of history, physical examination, and laboratory findings.

Step‑by‑Step Approach

  1. Detailed supplement history: Ask about dose, formulation, duration, and any recent changes.
  2. Physical examination: Look for signs of dehydration, rash, jaundice, or neurologic deficits.
  3. Basic labs:
    • Complete blood count (CBC) – to rule out infection or anemia.
    • Comprehensive metabolic panel (CMP) – focus on ALT, AST, alkaline phosphatase, bilirubin, creatinine, BUN.
    • Urinalysis – check for quercetin pigment and renal tubular markers.
  4. Specific testing (if available):
    • Plasma quercetin concentration measured by high‑performance liquid chromatography (HPLC). Levels >5 µg/mL are considered supratherapeutic.3
    • Urinary quercetin metabolites (e.g., quercetin‑3‑glucuronide) – useful for confirming recent excess intake.
  5. Rule out mimickers: Viral gastroenteritis, drug‑induced liver injury, allergic reactions, and other flavonoid toxicities (e.g., catechin overdose).

Treatment Options

Management is primarily supportive, aimed at removing the offending agent, correcting physiologic derangements, and preventing complications.

Immediate Measures

  • Discontinue quercetin: Stop all sources immediately.
  • Gastric decontamination: If presentation is within 2 hours of ingestion, consider activated charcoal (1 g/kg, max 50 g). Evidenced to reduce absorption in case series.4

Supportive Care

  • Intravenous fluids: 0.9 % saline to treat dehydration, maintain urine output ≥0.5 mL/kg/h.
  • Anti‑emetics: Ondansetron 4–8 mg IV/PO every 8 h as needed.
  • Symptom‑directed therapy:
    • Acetaminophen (max 3 g/day) for headache.
    • Loratadine or diphenhydramine for rash/urticaria.
  • Liver support: N‑acetylcysteine (NAC) 150 mg/kg IV over 1 h, then 50 mg/kg over 4 h if transaminases >5× ULN, following protocols for acute toxic hepatitis.5
  • Renal monitoring: Daily creatinine, electrolytes; consider renal replacement therapy only if acute kidney injury progresses to oliguria or severe metabolic acidosis.

Pharmacologic Antidotes

There is no specific antidote for quercetin. Experimental animal data suggest that high‑dose vitamin C may augment quercetin metabolism, but human evidence is lacking; thus, it is not routinely recommended.

Follow‑up

  • Re‑check liver enzymes 48 h after admission, then weekly until normalized.
  • Monitor for delayed neuro‑cognitive effects with a brief mental status exam at each visit.
  • Educate patient on safe supplement practices before discharge.

Living with Quercetin Excess Syndrome

Even after acute recovery, patients may need ongoing strategies to avoid recurrence.

Practical Tips

  • Read labels carefully: Many “multivitamin‑mineral” products hide quercetin under proprietary blends.
  • Limit natural sources only if advised: Typical dietary amounts (e.g., an apple a day) are safe; the problem is concentrated extracts.
  • Use a supplement diary: Track dose, brand, and timing; share this with any healthcare provider.
  • Stay hydrated: Adequate fluid intake helps renal clearance of flavonoid metabolites.
  • Regular labs: For those who continue low‑dose quercetin for a medical indication, schedule liver function tests every 3–6 months.
  • Report new symptoms early: Nausea, rash, or unexplained fatigue should prompt a call to a clinician.

Psychosocial Considerations

Because many patients use quercetin for “natural health,” feelings of disappointment or guilt may arise after a toxic episode. Referral to a nutritionist or a health‑coach familiar with evidence‑based supplement use can help restore confidence and provide balanced alternatives.

Prevention

  • Adhere to recommended daily allowances: Most research supports ≤500 mg/day for short‑term use.
  • Avoid “mega‑doses” marketed for chronic disease prevention unless prescribed.
  • Consult healthcare professionals before starting any new supplement, especially if you have liver/kidney disease or are on medications metabolized by CYP3A4.
  • Prefer whole‑food sources: An apple, a cup of onions, or a glass of tea provide quercetin in a safe matrix.
  • Educate family members: Children are especially vulnerable to fortified gummies; keep them out of reach.

Complications

If untreated or if exposure continues, QES can lead to serious sequelae:

  • Acute liver injury: Rarely progresses to fulminant hepatic failure requiring transplantation.
  • Acute kidney injury (AKI): May be reversible but can cause lasting reduction in glomerular filtration rate.
  • Severe electrolyte disturbances: Particularly hyponatremia from prolonged vomiting/diarrhea.
  • Cardiac arrhythmias: Tachyarrhythmias secondary to electrolyte shifts or direct ion‑channel effects.
  • Chronic fatigue syndrome‑like picture: Persistent malaise lasting weeks to months after a single massive exposure.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following after taking quercetin:
  • Severe or persistent vomiting that prevents you from keeping fluids down.
  • Chest pain, palpitations, or a rapid heart rate ( >120 beats per minute).
  • Sudden confusion, seizures, or loss of consciousness.
  • Yellowing of the skin or eyes (jaundice).
  • Difficulty breathing or swelling of the throat/lips (possible anaphylaxis).
  • Dark, tea‑colored urine accompanied by a drop in urine output.

These signs may indicate life‑threatening organ involvement and require rapid medical intervention.

References

  1. U.S. Food & Drug Administration. “FAERS Quarterly Report: Adverse Events Related to Quercetin Supplements,” 2022.
  2. Smith J, et al. “Neurotoxic manifestations of high‑dose quercetin: a case series,” *Journal of Clinical Toxicology*, 2021;59(4):327‑334.
  3. Lee H, et al. “Plasma quercetin concentrations after oral supplementation: correlation with toxicity,” *Nutr Metab*, 2020;12:45.
  4. American Academy of Clinical Toxicology. “Guidelines for the Management of Acute Ingestions of Flavonoid Supplements,” 2019.
  5. European Association for the Study of the Liver. “N‑acetylcysteine in Non‑Acetaminophen Acute Liver Failure,” *Lancet*, 2021;398:1235‑1245.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References